These results correlated well with previous observations in breast cancer [10], rectal cancer [16], renal cell carcinoma [11], which further supported the emerging role of KIAA0101 as a potential therapeutic target for cancer treatment. The gene discussed is PCLAF; the disease is breast cancer.